Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Diabetes’ link to obesity broken in mice

16.02.2005


Scientists at Washington University School of Medicine in St. Louis used genetically modified mice to uncover a potentially important link between diabetes and obesity.



By genetically altering production of a factor found in skeletal muscle, scientists produced mice that can’t get fat but do develop early signs of diabetes. Reversing the alteration produced mice that can become obese but do not develop diabetes. The findings provide important insights for scientists struggling to find new ways to cope with the unprecedented epidemic of obesity now spreading through the United States and other nations. Obesity brings with it a range of health consequences including sharply increased risk of type 2 diabetes, the most common form of diabetes.

Scientists broke the link to improve their understanding of the network of factors that lead from obesity to the onset of diabetes. Based on what they learned, they applied a drug treatment in their new transgenic mice and in a different, previously established mouse line that suffers from obesity and a diabetes-like condition. In both groups, the drug increased insulin sensitivity, which is a primary goal of diabetes treatment. "These results confirm that the links between obesity and diabetes show great promise as targets for new therapies that act as ’metabolic modulators’ in muscle," says senior author Daniel P. Kelly, M.D., professor of medicine, of pediatrics and of molecular biology and pharmacology.


The study appears in the February 2005 issue of Cell Metabolism. It reveals new details of the activities of the peroxisome proliferator-activated receptors (PPARs), a family of receptors that affects the way cells respond to energy resources.

Diabetes disrupts the body’s ability to manage energy resources including both fat and sugar. Insulin is a primary regulator of these resources. When the intake of calories exceeds the ability of the body to store them, insulin does not work as well, leading to an increase in blood sugar levels. The work by Kelly’s group shows that this problem starts by diversion of fats to muscle, triggering an abnormal activation of PPAR. PPAR in turn sends signals to the cells to stop responding to insulin, resulting in hazardously high blood sugar levels.

Kelly’s research group had previously shown that a member of the PPAR family, PPAR-alpha, was unusually active in heart and skeletal muscle of diabetic mice. PPAR-alpha normally becomes active in response to fats. It "revs up" the machinery cells use to make energy from fat, according to Kelly. "It’s an adaptive response that helps the cell deal with all the fat that’s coming in, but our notion was that it might also play a role in the development of diabetes," he explains. "We thought PPAR-alpha might also be telling cells, look, we have all this fat coming in, so we’re not going to need glucose to make energy, so let’s shut down glucose burning. And that’s exactly what happens in diabetes."

To test their ideas, Kelly and lead author Brian N. Finck, Ph.D., research instructor in medicine, engineered a line of mice with extra PPAR-alpha in their skeletal muscle. They found the mice’s skeletal muscle cells could "chew up" fat at remarkable speeds, preventing obesity even when the mice were fed a high-fat diet. Although they were lean, the mice were also "on their way to becoming diabetic," according to Kelly. Insulin resistance and glucose intolerance -- two key harbingers of diabetes -- increased in the mice. Kelly’s group traced the glucose intolerance to PPAR-alpha’s ability to shut down genes involved in glucose uptake and use. When Kelly’s lab tested a line of mice where PPAR-alpha had been genetically knocked out, they found the reverse was true. The mice could get just as obese as normal mice on a high-fat diet, but they did not develop early signs of diabetes.

Based on what they learned about PPAR-alpha’s effects, scientists gave a drug that inhibited an important enzyme in the processes that let muscle cells make energy from fat. PPAR-alpha normally activates this enzyme as part of its efforts to accelerate fat metabolism, and blocking it essentially tricked the cell into thinking that PPAR-alpha was no longer activated. Insulin sensitivity increased as a result.

To follow up, Kelly’s lab is attempting to rescue the new mouse line from glucose intolerance and insulin resistance. PPAR-alpha seems to convince cells that they don’t need glucose because they have plenty of energy available from fat, so Kelly will try to increase energy demand or trick cells into thinking they have less energy available. "One obvious experiment is to exercise the animals, increasing their muscle energy requirements to see if we can make them more insulin sensitive," Kelly says. "Another option is to develop ways to decrease the cellular accumulation of a compound known as ATP, which is the key product of cellular energy-making processes."

Michael C. Purdy | EurekAlert!
Further information:
http://www.wustl.edu

More articles from Life Sciences:

nachricht Researchers uncover protein-based “cancer signature”
05.12.2016 | Universität Basel

nachricht The Nagoya Protocol Creates Disadvantages for Many Countries when Applied to Microorganisms
05.12.2016 | Leibniz-Institut DSMZ-Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Shape matters when light meets atom

Mapping the interaction of a single atom with a single photon may inform design of quantum devices

Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...

Im Focus: Novel silicon etching technique crafts 3-D gradient refractive index micro-optics

A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.

Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...

Im Focus: Quantum Particles Form Droplets

In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.

“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...

Im Focus: MADMAX: Max Planck Institute for Physics takes up axion research

The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.

The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...

Im Focus: Molecules change shape when wet

Broadband rotational spectroscopy unravels structural reshaping of isolated molecules in the gas phase to accommodate water

In two recent publications in the Journal of Chemical Physics and in the Journal of Physical Chemistry Letters, researchers around Melanie Schnell from the Max...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ICTM Conference 2017: Production technology for turbomachine manufacturing of the future

16.11.2016 | Event News

Innovation Day Laser Technology – Laser Additive Manufacturing

01.11.2016 | Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

 
Latest News

NASA's AIM observes early noctilucent ice clouds over Antarctica

05.12.2016 | Earth Sciences

Shape matters when light meets atom

05.12.2016 | Physics and Astronomy

Researchers uncover protein-based “cancer signature”

05.12.2016 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>